SCOPUS 정보 검색 플랫폼

Volumn 61, Issue 8, 2001, Pages 3394-3398

E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs

(4) Zhou, Z a Jia, S F a Hung, M C a Kleinerman, E S a

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; NEU DIFFERENTIATION FACTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; EWING SARCOMA; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA CELL;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CISPLATIN; DNA TOPOISOMERASES, TYPE II; DOWN-REGULATION; DOXORUBICIN; ETOPOSIDE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, ERBB-2; GENETIC VECTORS; HUMANS; RECEPTOR, ERBB-2; SARCOMA, EWING'S; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0035870272 PISSN: 00085472 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (57)

References (30)

1
- 0004487372
- Bone tumors
- J. F. Holland, Bast, R. C., Morton, D. L., Frei, E., Kufe, D. W., and Weichselbaum, R. R. (eds.). Baltimore: Williams and Wilkins Waverly
- (1997) Cancer Medicine, Ed. 4 , pp. 2503-2553
- Rosen, G.¹ Forscher, C.A.² Mankin, H.J.³ Selch, M.C.⁴

2
- 0001867423
- Ewing's sarcoma family of tumors: Ewing's sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumor
- P. A. Pizzo and D. G. Poplack (eds.). Philadelphia: J. B. Lippincott
- (1994) Principles and Practice of Pediatric Oncology, Ed. 2 , pp. 795-821
- Horowitz, M.E.¹ Malawer, M.M.² DeLaney, T.F.³ Tsokos, M.G.⁴

3
- 0027423082
- Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma
- (1993) J. Clin. Oncol. , vol.11 , pp. 1911-1918
- Horowitz, M.E.¹ Kinsella, T.J.² Wexler, L.H.³ Belasco, J.⁴ Triche, T.⁵ Tsokos, M.⁶ Steinberg, S.M.⁷ McClure, L.⁸ Longo, D.L.⁹ Steis, R.G.¹⁰ Glatstein, E.¹¹ Pizzo, P.A.¹² Miser, J.S.¹³

4
- 9444220857
- Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors
- (1996) Cancer (Phila.) , vol.78 , pp. 901-911
- Wexler, L.H.¹ DeLaney, T.F.² Avila, N.³ Steinberg, S.M.⁴ Weaver-McClure, L.⁵ Jacobson, J.⁶ Jarosinski, P.⁷ Hijazi, Y.M.⁸ Balis, F.M.⁹ Horowitz, M.E.¹⁰

5
- 0027438755
- No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: Results of two sequential studies
- (1993) J. Chemother. , vol.5 , pp. 247-257
- Bacci, G.¹ Picci, P.² Ruggieri, P.³ Perrari, S.⁴ Mercuri, M.⁵ Fabbri, N.⁶ Campanacci, M.⁷

6
- 0027183531
- Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma
- (1993) J. Clin. Oncol. , vol.11 , pp. 1482-1488
- Burdach, S.¹ Jurgens, H.² Peters, C.³ Nurnberger, W.⁴ Mauz-Korholz, C.⁵ Paulussen, M.⁶ Pape, H.⁷ Dilloo, D.⁸ Koscielniak, E.⁹ Gadner, H.¹⁰ Gobel, U.¹¹

7
- 0029942068
- Treatment of femoral Ewing's sarcoma
- (1996) Cancer (Phila.) , vol.78 , pp. 70-78
- Terek, R.M.¹ Brien, E.W.² Marcove, R.C.³ Meyers, P.A.⁴ Lane, J.M.⁵ Healey, J.H.⁶

8
- 0024337144
- Studies of the Her2/neu proto-oncogene in human breast and ovarian cancer
- (1989) Science (Wash DC) , vol.244 , pp. 707-712
- Slamon, D.J.¹ Godophin, W.² Jones, L.A.³ Holt, J.A.⁴ Wong, S.G.⁵ Keith, D.E.⁶ Levin, W.J.⁷ Stuart, S.G.⁸ Udove, J.⁹ Ullrich, A.¹⁰ McGuire, W.L.¹¹

9
- 0025281906
- Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer
- (1990) Cancer Res. , vol.50 , pp. 4087-4091
- Berchuck, A.¹ Kamel, A.² Whitaker, R.³ Kerns, B.⁴ Olt, G.⁵ Kinney, R.⁶ Soper, J.T.⁷ Dodge, R.⁸ Clarke-Pearsor, D.L.⁹ Marks, P.¹⁰ McKenzie, S.¹¹ Yin, S.¹² Bast R.C., Jr.¹³

10
- 0028278501
- c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties
- (1994) Cancer Res. , vol.54 , pp. 3260-3266
- Yu, D.¹ Wang, S.-S.² Dulski, K.M.³ Tsai, C.-M.⁴ Nicolson, G.L.⁵ Hung, M.-C.⁶

11
- 0027409399
- Enhanced c-rebB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A
- (1993) Cancer Res. , vol.53 , pp. 891-898
- Yu, D.¹ Wolf, J.K.² Scanlon, M.³ Price, J.E.⁴ Hung, M.-C.⁵

12
- 13344285355
- erbB-2 expression is correlated with poor prognosis for patient with osteosarcoma
- (1995) Cancer (Phila.) , vol.77 , pp. 71-78
- Onda, M.¹ Matsuda, S.² Higski, S.³ Lijima, T.⁴ Fukushima, J.⁵ Yokokura, A.⁶ Kojima, T.⁷ Horiuchi, H.⁸ Kurokawa, T.⁹ Yamamoto, T.¹⁰

13
- 0032856174
- Expression of HER2/rebB-2 correlates with survival in osteosarcoma
- (1999) Clin. Oncol. , vol.17 , pp. 2781-2791
- Gorlick, R.¹ Huvos, A.G.² Heller, G.³ Aledo, A.⁴ Beardsley, G.P.⁵ Healey, J.H.⁶ Meyers, P.A.⁷

14
- 0028943683
- neu level in HER2/neu-transfected human lung cancer cells
- (1995) J. Natl. Cancer Inst. , vol.87 , pp. 682-684
- Tsai, T.-C.¹ Yu, D.² Chang, K.-T.³ Wu, L.-H.⁴ Perng, R.-P.⁵ Ibrahim, N.K.⁶ Hung, M.-C.⁷

15
- 0029830451
- Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms
- (1996) Oncogene , vol.13 , pp. 1359-1365
- Yu, D.¹ Liu, B.² Tan, M.³ Li, J.⁴ Wang, S.-S.⁵ Hung, M.-C.⁶

16
- 17444448391
- The Ets protein PEA3 suppresses HER2/neu overexpression and inhibits tumorigenesis
- (2000) Nat. Med. , vol.6 , pp. 189-195
- Xing, X.¹ Wang, S.-C.² Zou, Y.³ Xia, X.Y.⁴ Shao, R.⁵ Kwong, K.Y.⁶ Yu, Z.⁷ Zhang, S.⁸ Miller, S.⁹ Huang, L.¹⁰ Hung, M.C.¹¹

17
- 0028354305
- c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer
- (1999) N. Engl. J. Med. , vol.330 , pp. 1260-1266
- Muss, H.B.¹ Thor, A.D.² Berry, D.A.³ Kte, T.⁴ Liu, E.⁵ Koerner, F.⁶ Cirrincione, C.T.⁷ Budman, D.R.⁸ Wood, W.C.⁹ Barcos, M.¹⁰ Henderson, I.C.¹¹

18
- 0000035666
- Targeting HER-2/neu overexpressing cancer cells with transcriptional repressor genes delivered by cationic liposome
- L. Hung, M-C. Hung, and E. Wagner (eds.). San Diego: Academic Press
- (1999) Cancer Gene Therapy using Cationic Liposome: Preclinic and Clinic Studies , pp. 357-377
- Hung, M.C.¹ Wang, S.C.² Hortobagyi, G.N.³

19
- 0025301503
- Transcriptional repression of the neu protooncogene by the adenovirus 5 EIA gene products
- (1990) Proc. Natl. Acad. Science USA , vol.87 , pp. 4499-4450
- Yu, D.¹ Suen, T.-C.² Yan, D.-H.³ Chang, L.-S.⁴ Hung, M.-C.⁵

20
- 0028823833
- Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER2/neu
- (1995) Oncogene , vol.11 , pp. 1383-1388
- Yu, D.¹ Matin, A.² Xia, W.³ Sorgi, F.⁴ Hung, L.⁵ Hung, M.-C.⁶

21
- 0033978815
- E1A-mediated paclitaxel sensitization in HER2/neu-overexpression ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway
- (2000) Clin. Cancer Res. , vol.6 , pp. 250-259
- Ueno, N.T.¹ Bartholomeusz, C.² Herrmann, J.L.³ Estrov, Z.⁴ Shao, R.⁵ Andreeff, P.⁶ Yu, D.⁷ Hung, M.-C.⁸

22
- 0002025785
- Manipulation of adenovirus vector. Gene transfer and expression protocols
- E. J. Murray (ed.). Clifton, NJ: The Humana Press
- (1991) Methods in Molecular Biology , vol.7 , pp. 109-128
- Graham, F.L.¹ Prevec, L.²

23
- 0026787419
- Test for chemotherapeutic sensitivity of cerebral gliomas: Use of colorimetric MTT assay
- (1992) J. Neuro-Oncol. , vol.14 , pp. 19-35
- Jordan, J.P.¹ Hand, C.M.² Markowitz, R.S.³ Black, P.⁴

24
- 0025726216
- A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
- (1991) J. Immunol. Methods , vol.139 , pp. 271-279
- Nicoletti, I.¹ Migliorati, G.² Pagliacci, M.C.³ Grignani, F.⁴ Riccardi, C.⁵

25
- 0025190758
- Expression of the neu gene-encoded protein (p185/neu) in human non-small cell carcinomas of the lung
- (1990) Cancer Res. , vol.50 , pp. 421-425
- Weiner, D.B.¹ Nordberg, J.² Robinson, R.³ Nowell, P.C.⁴ Gazdar, A.⁵ Greene, M.I.⁶ William, W.V.⁷ Cohen, J.A.⁸ Kern, J.A.⁹

26
- 0031816634
- The erbB2 gene as a cancer therapeutic target and the tumor and metastasis suppressing function of E1A
- (1998) Cancer Metastasis Rev. , vol.17 , pp. 195-202
- Yu, D.¹ Hung, M.-C.²

27
- 0030880078
- Chemosensitization of HER2/neu overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 EIA
- (1997) Oncogene , vol.15 , pp. 953-960
- Ueno, N.T.¹ Yu, D.² Hung, M.-C.³

28
- 0030980486
- Involvement of co-activator p300 in the transcriptional regulation of the HER-2/neu gene
- (1997) J. Biol. Chem. , vol.272 , pp. 6101-6104
- Chen, H.¹ Hung, M.-C.²

29
- 0033568541
- Adenovirus-mediated human topoisomerase II a gene transfer increases sensitivity of etoposide-resistant human breast cancer cells
- (1999) Cancer Res. , vol.59 , pp. 4618-4624
- Zhou, Z.¹ Zwelling, L.A.² Kawakarru, Y.³ An, T.⁴ Kobayashi, K.⁵ Herzog, C.⁶ Kleinerman, E.S.⁷

30
- 0032504347
- A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER2/neu or epithelial ovarian cancer
- (1998) Hum. Gene Ther. , vol.9 , pp. 1775-1798
- Hortobagyi, G.N.¹ Carey, M.M.² Hung, M.-C.³ Lopez, G.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.